Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: A review of single- and multicenter retrospective studies from 2006 to 2010

Dermatologic Surgery

Volumn 39, Issue 3 PART 1, 2013, Pages 345-364

  Mudigonda, Tejaswi ^a   Levender, Michelle M ^a   O'Neill, Jenna L ^a   West, Cameron E ^a   Pearce, Daniel J ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; ALUMINUM; ANTACID AGENT; AZATHIOPRINE; AZITHROMYCIN; BASILIXIMAB; CLARITHROMYCIN; COLESTYRAMINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; CYCLOSPORIN A; DILTIAZEM; ERYTHROMYCIN; FINGOLIMOD; GANCICLOVIR; KETOCONAZOLE; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; OKT 3; PROBENECID; RAPAMYCIN; RIFAMPICIN; SALICYLIC ACID; TACROLIMUS; TOLBUTAMIDE; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ALLERGIC REACTION; ALOPECIA; ANEMIA; BASAL CELL CARCINOMA; BONE DISEASE; BRAIN DISEASE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CLINICAL DECISION MAKING; CUSHING DISEASE; DIABETES MELLITUS; DIARRHEA; DYSPEPSIA; FATIGUE; GASTROINTESTINAL TOXICITY; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LEUKOPENIA; LYMPHOCYTOPENIA; LYMPHOMA; MEDLINE; MELANOCYTIC NEVUS; MELANOMA; MERKEL CELL TUMOR; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; ORGAN TRANSPLANTATION; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; RISK FACTOR; SEX; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUNLIGHT; THROMBOCYTOPENIA;

AGE FACTORS; CARCINOMA, MERKEL CELL; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MELANOMA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SEX FACTORS; SKIN NEOPLASMS; SUNLIGHT;

EID: 84874668422     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12028     Document Type: Review

References (134)

1. Otley CC, Griffin MD, Charlton MR, Edwards BS, et al. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks. Br J Dermatol 2007; 157 (6): 1183-8.
2. Berg D, Otley CC,. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47 (1): 1-17;quiz 18-20.
3. Penn I,. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7 (2): 147-56.
4. Kovach BT, Stasko T,. Skin cancer after transplantation. Transplant Rev (Orlando) 2009; 23 (3): 178-89.
5. Mukherjee S, Mukherjee U,. A comprehensive review of immunosuppression used for liver transplantation. J Transplant 2009; 2009: 701464.
6. Sharma VK, Li B, Khanna A, Sehajpal PK, et al. Which way for drug-mediated immunosuppression? Curr Opin Immunol 1994; 6 (5): 784-90.
7. Sheil AG, May J, Mahoney JF, Horvath JS, et al. Incidence of cancer in renal transplant recipients. Proc Eur Dial Transplant Assoc 1980; 17: 502-6.
8. Edwards NM, Rajasinghe HA, John R, Chen JM, et al. Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University. Clin Transpl 1999; 11: 249-61.
9. Penn I,. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000; 23 (2): 101-13.
10. Fekecs T, Kadar Z, Battyani Z, Kalmár-Nagy K, et al. Incidence of nonmelanoma skin cancer after human organ transplantation: single-center experience in Hungary. Transplant Proc 2010; 42 (6): 2333-5.
11. Euvrard S, Kanitakis J, Pouteil-Noble C, Disant F, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27 (2): 1767-8.
12. Adamson R, Obispo E, Dychter S, Dembitsky W, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998; 30 (4): 1124-6.
13. Pollard JD, Hanasono MM, Mikulec AA, Le QT, et al. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000; 110 (8): 1257-61.
14. Veness MJ,. Aggressive skin cancers in a cardiac transplant recipient. Australas Radiol 1997; 41 (4): 363-6.
15. Stockfleth E, Ulrich C, Meyer T, Christophers E,. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160: 251-8.
16. Caforio AL, Fortina AB, Piaserico S, Alaibac M, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 19 (Suppl 3): III222-7.
17. Barr BB, Benton EC, McLaren K, Bunney MH, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1 (8630): 124-9.
18. Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 1: 222-9.
19. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49 (3): 506-9.
20. Ong CS, Keogh AM, Kossard S, Macdonald PS, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40 (1): 27-34.
21. Lampros TD, Cobanoglu A, Parker F, Ratkovec R, et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17 (6): 586-91.
22. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154 (3): 498-504.
23. Comeau S, Jensen L, Cockfield SM, Sapijaszko M, et al. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience. Transplantation 2008; 86 (4): 535-41.
24. Crespo-Leiro MG, Alonso-Pulpon LA, Villa-Arranz A, Brossa-Loidi V, et al. The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry. Transplant Proc 2010; 42 (8): 3011-3.
25. Basic-Jukic N, Bubic-Filipi L, Prgomet D, Djanic̈ Hadzibegovic̈ A, et al. Head and neck malignancies in Croatian renal transplant recipients. Bosn J Basic Med Sci 2010; 10 (Suppl 1): S37-9.
26. Perera GK, Child FJ, Heaton N, O'Grady J, et al. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Br J Dermatol 2006; 154 (5): 868-72.
27. Navarro MD, Lopez-Andreu M, Rodriguez-Benot A, Aguera ML, et al. Cancer incidence and survival in kidney transplant patients. Transplant Proc 2008; 40 (9): 2936-40.
28. Marques Medina E, Jimenez Romero C, Gomez de la Camara A, Rota Bernal A, et al. Malignancy after liver transplantation: cumulative risk for development. Transplant Proc 2009; 41 (6): 2447-9.
29. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61 (5): 715-21.
30. Kalinova L, Majek O, Stehlik D, Krejci K, et al. Skin cancer incidence in renal transplant recipients-a single center study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010; 154 (3): 257-60.
31. Tessari G, Naldi L, Boschiero L, Nacchia F, et al. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol 2010; 146 (3): 294-9.
32. Molina BD, Leiro MG, Pulpon LA, Mirabet S, et al. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. Transplant Proc 2010; 42 (8): 3001-5.
33. Vegso G, Toth M, Hidvegi M, et al. Malignancies after renal transplantation during 33 years at a single center. Pathol Oncol Res 2007; 13 (1): 63-9.
34. Keller B, Braathen LR, Marti HP, Hunger RE,. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly 2010; 140: w13036.
35. Wisgerhof HC, van der Boog PJ, de Fijter JW, Wolterbeek R, et al. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients. J Invest Dermatol 2009; 129 (12): 2886-94.
36. Euvrard S, Kanitakis J, Claudy A,. Skin cancers after organ transplantation. N Engl J Med 2003; 348 (17): 1681-91.
37. Purdie KJ, Surentheran T, Sterling JC, Bell L, et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 2005; 125 (1): 98-107.
38. Harwood CA, Surentheran T, Sasieni P, Proby CM, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150 (5): 949-57.
39. Shamanin V, zur Hausen H, Lavergne D, Proby CM, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88 (12): 802-11.
40. Stockfleth E, Nindl I, Sterry W, Ulrich C, et al. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 2: 604-9.
41. Meyer T, Arndt R, Nindl I, Ulrich C, et al. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 2003; 16 (3): 146-53.
42. Zamanian A, Mahjub H, Mehralian A,. Skin diseases in kidney transplant recipients. Urol J. Fall 2006; 3 (4): 230-3.
43. Stockfleth E, Ulrich C, Meyer T, Arndt R, et al. Skin diseases following organ transplantation-risk factors and new therapeutic approaches. Transplant Proc. 2001; 33 (1-2): 1848-18530.
44. Boyle J, MacKie RM, Briggs JD, Junor BJ, et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1 (8379): 702-5.
45. Jaeger AB, Gramkow A, Hjalgrim H, Melbye M, et al. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol 1999; 135 (7): 790-3.
46. Neubert T, Lehmann P,. Bowen's disease-a review of newer treatment options. Ther Clin Risk Manag 2008; 4 (5): 1085-95.
47. Drake AL, Walling HW,. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients. J Am Acad Dermatol 2008; 59 (1): 68-71.
48. Koukourgianni F, Harambat J, Ranchin B, Euvrard S, et al. Malignancy incidence after renal transplantation in children: a 20-year single-centre experience. Nephrol Dial Transplant 2010; 25 (2): 611-6.
49. Henquet C,. Anogenital malignancies and pre-malignancies. J Eur Acad Dermatol Venereol 2011; 25: 885-95.
50. Hansen JP, Drake AL, Walling HW,. Bowen's Disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg 2008; 34 (7): 878-83.
51. Sarid R, Sato T, Bohenzky RA, Russo JJ, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 1997; 3 (3): 293-8.
52. Cesarman E,. Kaposi's sarcoma-associated herpesvirus-the high cost of viral survival. N Engl J Med 2003; 349 (12): 1107-9.
53. Mesri EA, Cesarman E, Boshoff C,. Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer 2010; 10 (10): 707-19.
54. Babal P, Pec J,. Kaposi's sarcoma-still an enigma. J Eur Acad Dermatol Venereol 2003; 17 (4): 377-80.
55. Buonaguro FM, Tomesello ML, Buonaguro L, Satriano RA, et al. Kaposi's sarcoma: aetiopathogenesis, histology and clinical features. J Eur Acad Dermatol Venereol 2003; 17 (2): 138-54.
56. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C,. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4 (6): 905-13.
57. Penn I,. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998: 147-58.
58. Abbaszadeh S, Taheri S,. Kaposi's sarcoma after renal transplantation. Saudi J Kidney Dis Transpl 2009; 20 (5): 775-8.
59. Amital A, Shitrit D, Raviv Y, et al. Development of malignancy following lung transplantation. Transplantation 2006; 81 (4): 547-51.
60. Baccarani U, Piselli P, Serraino D, Bendayan D, et al. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis 2010; 42 (1): 55-60.
61. Harzallah K, Abderrahim E, Chareffedine K, Yeich S, et al. Cancers after renal transplantation: multicenter experience. Saudi J Kidney Dis Transpl 2008; 19 (5): 825-30.
62. Einollahi B, Lessan-Pezeshki M, Nourbala MH, Simforoosh N, et al. Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients. Int Urol Nephrol 2009; 41 (3): 679-85.
63. Penn I,. Sarcomas in organ allograft recipients. Transplantation 1995; 60 (12): 1485-91.
64. Donia AF, Mostafa A, Refaie H, El-Baz M, et al. Postkidney transplant malignancy in Egypt has a unique pattern: a three-decade experience. Transplantation 2008; 86 (8): 1139-42.
65. Tessari G, Naldi L, Piaserico S, Boschiero L, et al. Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study. Clin Transplant 2010; 24 (3): 328-33.
66. Serraino D, Piselli P, Angeletti C, Minetti E, et al. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005; 92 (3): 572-5.
67. Zwald FO, Christenson LJ, Billingsley EM, Zeitouni NC, et al. Melanoma in solid organ transplant recipients. Am J Transplant 2010; 10 (5): 1297-304.
68. Dinh QQ, Chong AH,. Melanoma in organ transplant recipients: the old enemy finds a new battleground. Australas J Dermatol 2007; 48 (4): 199-207.
69. Menzies SW, McCarthy WH,. Complete regression of primary cutaneous malignant melanoma. Arch Surg 1997; 132 (5): 553-6.
70. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77 (7): 1303-10.
71. Halliday GM, Patel A, Hunt MJ, Tefany FJ, et al. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg 1995; 19 (3): 352-8.
72. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci U S A 1994; 91 (9): 3515-9.
73. Jensen P, Moller B, Hansen S,. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000; 1: 307.
74. Penn I,. De novo malignances in pediatric organ transplant recipients. Pediatr Transplant 1998; 2 (1): 56-63.
75. Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev 2009; 18 (8): 2297-303.
76. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F,. Melanomas in renal transplant recipients. Br J Dermatol 2006; 154 (3): 472-7.
77. Dapprich DC, Weenig RH, Rohlinger AL, Weaver AL, et al. Outcomes of melanoma in recipients of solid organ transplant. J Am Acad Dermatol 2008; 59 (3): 405-17.
78. Wilson RE, Hager EB, Hampers CL, Corson JM, et al. Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med 1968; 278 (9): 479-83.
79. Jeremy D, Farnsworth RH, Robertson MR, Annetts DL, et al. Transplantation of malignant melanoma with cadaver kidney. Transplantation 1972; 13 (6): 619-20.
80. Cotter MA, Tristani-Firouzi P,. Unsuitability of organ donation from a patient with a history of melanoma? J Am Acad Dermatol 2006; 54 (6): 1096-8.
81. Crowley NJ, Seigler HF,. Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg 1990; 212 (2): 173-7.
82. Ozsoy Z, Ozyigit MT, Turkaslan T, Gulluoglu MG,. Ultralate metastasis of cutaneous melanoma. Dermatol Surg 2006; 32 (10): 1287-9.
83. Tsao H, Cosimi AB, Sober AJ,. Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 1997; 79 (12): 2361-70.
84. Schmid-Wendtner MH, Baumert J, Schmidt M, Konz B, et al. Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol 2000; 43 (4): 605-9.
85. Schmitt C, Cire K, Schattenkirchner S, Pollok M, et al. Highly sensitive DNA typing for detecting tumors transmitted by transplantation. Transpl Int 1998; 11 (5): 382-6.
86. Morris-Stiff G, Steel A, Savage P, Devlin J, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 2004; 4 (3): 444-6.
87. Cankovic M, Linden MD, Zarbo RJ,. Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med 2006; 130 (4): 529-32.
88. Buell JF, Beebe TM, Trofe J, Gross TG, et al. Donor transmitted malignancies. Ann Transplant 2004; 9 (1): 53-6.
89. Elder GJ, Hersey P, Branley P,. Remission of transplanted melanoma-clinical course and tumour cell characterisation. Clin Transplant 1997; 11 (6): 565-8.
90. Suranyi MG, Hogan PG, Falk MC, Axelsen RA, et al. Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation 1998; 66 (5): 655-61.
91. Penn I,. Transmission of cancer from organ donors. Ann Transplant 1997; 2 (4): 7-12.
92. Krejci K, Zadrazil J, Tichy T, Horák P, et al. [Merkel cell skin carcinoma]. Klin Onkol 2010; 23 (4): 210-7.
93. Buell JF, Trofe J, Hanaway MJ, Beebe TM, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002; 34 (5): 1780-1.
94. Miller RW, Rabkin CS,. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8 (2): 153-8.
95. Penn I, First MR,. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68 (11): 1717-21.
96. Goessling W, McKee PH, Mayer RJ,. Merkel cell carcinoma. J Clin Oncol 2002; 20 (2): 588-98.
97. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319 (5866): 1096-100.
98. Rollison DE, Giuliano AR, Becker JC,. New virus associated with merkel cell carcinoma development. J Natl Compr Canc Netw 2010; 8 (8): 874-80.
99. Koljonen V, Kukko H, Tukiainen E, Böhling T, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24 (10): 3231-5.
100. Baccarani U, Adani GL, Montanaro D, Risaliti A, et al. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases. Transplant Proc 2006; 38 (4): 1135-7.
101. Urbatsch A, Sams WM Jr, Urist MM, Sturdivant R,. Merkel cell carcinoma occurring in renal transplant patients. J Am Acad Dermatol 1999; 2: 289-91.
102. Stempfle HU, Mudra H, Angermann CE, Weiss M, et al. Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. J Heart Lung Transplant 1993; 12 (3): 501-3.
103. Traest K, De Vos R, van den Oord JJ,. Pagetoid Merkel cell carcinoma: speculations on its origin and the mechanism of epidermal spread. J Cutan Pathol 1999; 26 (7): 362-5.
104. Gooptu C, Woollons A, Ross J, Price M, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137 (4): 637-41.
105. Agelli M, Clegg LX,. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003; 49 (5): 832-41.
106. O'Reilly F, Traywick C, Pennie ML, Foster JK, et al. Baseline quality of life and anxiety in solid organ transplant recipients: a pilot study. Dermatol Surg 2006; 32 (12): 1480-5.
107. Moloney FJ, Keane S, O'Kelly P, Conlon PJ, et al. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 2005; 153 (3): 574-8.
108. Reichrath J, Nurnberg B,. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol 2008; 624: 203-14.
109. Traywick C, O'Reilly FM,. Management of skin cancer in solid organ transplant recipients. Dermatol Ther 2005; 18 (1): 12-8.
110. Terhorst D, Drecoll U, Stockfleth E, Ulrich C,. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol 2009; 161 (Suppl 3): 85-9.
111. Otley CC, Cherikh WS, Salasche SJ, McBride MA, et al. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005; 53 (5): 783-90.
112. Ismail F, Mitchell L, Casabonne D, Gulati A, et al. Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. Br J Dermatol 2006; 155 (5): 916-25.
113. Clowers-Webb HE, Christenson LJ, Phillips PK, Roenigk RK, et al. Educational outcomes regarding skin cancer in organ transplant recipients: randomized intervention of intensive vs standard education. Arch Dermatol 2006; 142 (6): 712-8.
114. Querings K, Reichrath J,. A plea for the analysis of Vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS). Cancer Causes Control 2004; 15 (2): 219.
115. Querings K, Girndt M, Geisel J, Georg T, et al. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab. 2006; 91 (2): 526-9.
116. Grant WB,. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002; 94 (6): 1867-75.
117. Kessler M, Jay N, Molle R, Guillemin F,. Excess risk of cancer in renal transplant recipients. Transpl Int 2006; 19 (11): 908-14.
118. Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 2 (8673): 1176-8.
119. Ulrich C, Jurgensen JS, Degen A, Hackethal M, et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161 (Suppl 3): 78-84.
120. Otley CC, Berg D, Ulrich C, Stasko T, et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006; 154 (3): 395-400.
121. Otley CC, Maragh SL,. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005; 31 (2): 163-8.
122. Dantal J, Hourmant M, Cantarovich D, Giral M, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351 (9103): 623-8.
123. Moloney FJ, Kelly PO, Kay EW, Conlon P, et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 2004; 2: 674-8.
124. Euvrard S, Kanitakis J, Decullier E, Butnaru AC, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81 (8): 1093-100.
125. Fortina AB, Piaserico S, Caforio AL, Abeni D, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140 (9): 1079-85.
126. Soulillou JP, Giral M,. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001; 12 (Suppl): S89-93.
127. Kirk AD, Mannon RB, Swanson SJ, Hale DA,. Strategies for minimizing immunosuppression in kidney transplantation. Transpl Int 2005; 18 (1): 2-14.
128. Feng WW, Wang TN, Chen HC, Ho JC, et al. Malignancies after renal transplantation in southern Taiwan: experience in one centre. BJU Int 2007; 99 (4): 825-9.
129. Arichi N, Kishikawa H, Nishimura K, Mitsui Y, et al. Malignancy following kidney transplantation. Transplant Proc 2008; 40 (7): 2400-2.
130. Aseni P, Vertemati M, De Carlis L, Sansalone CV, et al. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation. Pathol Int 2006; 56 (11): 712-5.
131. Popov Z, Ivanovski O, Kolevski P, Stankov O, et al. De novo malignancies after renal transplantation-a single-center experience in the Balkans. Transplant Proc 2007; 39 (8): 2589-91.
132. Chen PL, Chang HH, Chen IM, Lai ST, et al. Malignancy after heart transplantation. J Chin Med Assoc 2009; 72 (11): 588-93.
133. Altaee IK, Jaleel NA, Aljubury HM, Alshamaa IA, et al. Incidence and types of malignancies in renal transplant recipients in Iraq. Saudi J Kidney Dis Transpl 2006; 17 (3): 408-14.
134. Romero-Vargas ME, Flores-Cortes M, Valera Z, Gõmez-Bravo MA, et al. Cancers of new appearance in liver transplant recipients: incidence and evolution. Transplant Proc 2006; 38 (8): 2508-10.